Risk factors for functional limitations in patients with long-standing ankylosing spondylitis.
about
The health-related quality of life of ankylosing spondylitis patients assessed by SF-36: a systematic review and meta-analysis.Challenges comparing functional limitations in rheumatoid arthritis and ankylosing spondylitisPsychological correlates of self-reported functional limitation in patients with ankylosing spondylitis.Ankylosing spondylitis: patterns of radiographic involvement--a re-examination of accepted principles in a cohort of 769 patients.The contribution of disease activity on functional limitations over time through psychological mediators: a 12-month longitudinal study in patients with ankylosing spondylitisAre there gender differences in severity of ankylosing spondylitis? Results from the PSOAS cohort.Effect of cigarette smoking and alcohol consumption on disease activity and physical functioning in ankylosing spondylitis: a cross-sectional study.Regional radiographic damage and functional limitations in patients with ankylosing spondylitis: differences in early and late disease.Factors associated with a bad functional prognosis in early inflammatory back pain: results from the DESIR cohort.Functional limitations due to axial and peripheral joint impairments in patients with ankylosing spondylitis: are focused measures more informative?Clinical and immunogenetic prognostic factors for radiographic severity in ankylosing spondylitisOccupational physical activities and long-term functional and radiographic outcomes in patients with ankylosing spondylitis.MICA, a gene contributing strong susceptibility to ankylosing spondylitis.Increasing smoking intensity is associated with increased disease activity in axial spondyloarthritis.Spondyloarthritis and smoking: towards a new insight into the disease.Variables related to work productivity loss in patients with ankylosing spondylitis.Physical activity in axial spondyloarthritis-tails from bench to bedside.Impact of tobacco smoking on response to tumour necrosis factor-alpha inhibitor treatment in patients with ankylosing spondylitis: results from the Danish nationwide DANBIO registry.Adherence to treatment in patients with ankylosing spondylitis.Demographic, clinical, laboratory and treatment characteristics of spondyloarthritis patients with and without acute anterior uveitis.Association of cigarette smoking with Chinese ankylosing spondylitis patients in Taiwan: a poor disease outcome in systemic inflammation, functional ability, and physical mobility.Quality of life in patients with ankylosing spondylitis: relationships with spinal mobility, disease activity and functional status.Continuous Improvement of Physical Functioning in Ankylosing Spondylitis Patients by Tumor Necrosis Factor Inhibitors: Three-Year Followup and Predictors.Is there any gender-specific difference in the cut-off values of ankylosing spondylitis disease activity score in patients with axial spondyloarthritis?Female patients with ankylosing spondylitis: analysis of the impact of gender across treatment studies.Predictors of radiographic severity and functional disability in Turkish patients with ankylosing spondylitis.[German Society for Rheumatology S3 guidelines on axial spondyloarthritis including Bechterew's disease and early forms: 7 Disease activity and prognosis of spondyloarthritis].Q56769818DGRh-S3-Leitlinie Axiale Spondyloarthritis inklusive Morbus Bechterew und FrühformenFactors Associated with Severe Skin Infections in Patients Treated with Biologic Therapies for Inflammatory Rheumatic Diseases
P2860
Q30249502-772606BE-DF4C-42BB-BEF7-4AA47DD49090Q34192955-0567C4CA-4674-44F0-A21E-7C0BFDA87314Q34413304-ABFBB414-CD8E-4AFA-9031-78D3BAB7C02CQ34436388-E2FCA7CA-51BA-47AE-AC39-8E05B6BEE52AQ35415646-A051AA3E-73F8-4EA7-BBDE-D2D14C0AC9D7Q35953260-16AEB829-EE03-4CDF-B1D6-D8667ECA0383Q36183359-A6AB58B1-66C5-473F-B185-8FAE060A3259Q36522063-B718531F-A5AF-4AA3-87EF-C23C9C0A4A26Q36559856-672F0077-F7E8-4883-B88B-4C2C23C5C2C4Q36595046-EA619579-689B-40C1-9BE0-EC0D3DE31547Q37261155-F9E65C5C-C39D-4953-8329-6F5D6F3CD31BQ37307268-B6FBAD62-CD55-4E3D-A26F-BBC362C58483Q37416790-6AD39E29-6077-4B3E-982A-89D4C330FA9DQ37601459-FE0012CE-2D6C-4795-9651-E5F910DAA796Q38111419-D3F8622B-E4A6-4F4E-A74E-975A36894C24Q38139808-2585353C-CDA8-40CF-B529-8C12071D9735Q38818601-E97B1A87-B0DC-4E26-8195-71811917B186Q40251018-BBE45474-D498-46A9-A224-7F4740D8FC82Q44902283-3E3D1DF7-E305-4CCA-AA6C-187A82C376B0Q46033500-484CB24B-F9D2-4851-96CB-954FAE212E35Q48315650-788CE502-FD07-43D2-9EFB-C6D82CD8CBA3Q48917235-49ECABD1-BBBD-4E77-931A-3B3232290B01Q50879886-FB39583B-7F9C-4932-AFDB-3E14DD24A3E6Q50886436-938AAE59-A85C-4DB9-88AC-D5320F4853FCQ51286442-1F0BA28E-2047-4050-A6D2-6127B2D5C29CQ51519966-09E8A1CE-146D-42F8-AA76-52502B15DF34Q52874133-8A740CCC-A772-4C01-A151-B9E1848BE4EAQ56769818-E3D52179-54D9-48C2-A675-A17621D474FCQ57605596-A645E850-4FE0-4362-B068-D28EF8D628C4Q58003948-78DF2F0B-94D0-4FC6-B24A-FCBED4E4435A
P2860
Risk factors for functional limitations in patients with long-standing ankylosing spondylitis.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Risk factors for functional li ...... anding ankylosing spondylitis.
@en
type
label
Risk factors for functional li ...... anding ankylosing spondylitis.
@en
prefLabel
Risk factors for functional li ...... anding ankylosing spondylitis.
@en
P2093
P2860
P356
P1476
Risk factors for functional li ...... anding ankylosing spondylitis.
@en
P2093
John C Davis
Michael H Weisman
Michael M Ward
P2860
P304
P356
10.1002/ART.21444
P577
2005-10-01T00:00:00Z